PR Newswire | Nov 3, 2021 08:01AM EDT

11/03 07:00 CDT

Insmed To Participate in Three November Conferences BRIDGEWATER, N.J., Nov. 3, 2021

BRIDGEWATER, N.J., Nov. 3, 2021 /PRNewswire/ -- Insmed Incorporated Inc. (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will participate in the following virtual investor conferences:

* The Credit Suisse 30th Annual Virtual Healthcare Conference on November 9, 2021 at 10:30 a.m. ET in a fireside chat * The Stifel 2021 Virtual Healthcare Conference on November 17, 2021 at 8:40 a.m. ET in a fireside chat * The Evercore ISI 4th Annual HealthCONx Virtual Conference on November 30, 2021 at 8:00 a.m. ET in a fireside chat

Each fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com. Each webcast will be archived for a period of 30 days following the conclusion of each live event.

About InsmedInsmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Eleanor BarisserAssociate Director, Investor RelationsInsmed(718) 594-5332eleanor.barisser@insmed.com

Media:

Mandy FaheySenior Director, Corporate CommunicationsInsmed(732) 718-3621amanda.fahey@insmed.com

View original content to download multimedia: https://www.prnewswire.com/news-releases/insmed-to-participate-in-three-november-conferences-301414353.html

SOURCE Insmed Incorporated